ARTICLE | Clinical News
VIMRxyn: Received regulatory approval in Thailand to begin a Phase Ib trial in 24 infected patients to determine an effective dose with minimal skin photosensit
November 13, 1995 8:00 AM UTC
VIMRx Pharmaceuticals Inc. (VMRX) Product: VIMRxyn, hypericin antiviral Indication: HIV Status: Received regulatory approval in Thailand to begin a Phase Ib trial in 24 infected patients to determine ...